Conference Coverage

Substance use increases likelihood of psychiatric hold in pregnancy


 

REPORTING FROM THE AAPL ANNUAL MEETING

Laws on pregnancy, substance use

Dr. House considered those findings within the context of current laws governing substance use during pregnancy. Currently, 18 states, mostly throughout the South and Midwest, regard drug abuse during pregnancy as child abuse, with prosecution usually requiring detection of the substance at birth or during pregnancy, or evidence of risk to the child’s health.

Tennessee is unique in considering substance abuse in pregnancy assault if the child is born with dependence or other harm from the drug use. Women in Minnesota, South Dakota, and Wisconsin can be subject to civil commitment, including required inpatient drug treatment, for substance abuse during pregnancy (Am J Psychiatry. 2016 Nov 1;173[11]:1077-80).

Mandatory reporting laws for suspected substance abuse during pregnancy exist in 15 states, mostly in the Southwest, northern Midwest, and states around the District of Columbia. And four states – Kentucky, Iowa, Minnesota, and North Dakota – require pregnant women suspected of substance abuse to be tested.

Yet, most major relevant medical associations oppose criminalization of substance use during pregnancy, including the American Psychiatric Association, the American Academy of Addiction Psychiatry, the American Medical Association, and the American College of Obstetricians and Gynecologists.

“They are generally for increasing access for people, like voluntary screening, but against criminalization because it creates a barrier to accessing prenatal care,” Dr. House explained.

Aside from the question of whom psychiatrists consider their patients – the woman, her fetus, or both – the results raise another question, Dr. House said: “While studies have shown that criminalizing substance use during pregnancy discourages mothers from seeking prenatal care, does the threat of an involuntary psychiatric admission have a similar consequence?” That’s a question for further research.

No external funding was used. Dr. House was a clinical investigator without compensation for Janssen Pharmaceuticals from 2015 to 2017.

Pages

Recommended Reading

Many teens don’t know e-cigarettes contain nicotine
MDedge Family Medicine
Cigarette smoking at lowest level ever
MDedge Family Medicine
Identifying and stopping a likely mass shooter: A case study
MDedge Family Medicine
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
MDedge Family Medicine
Despite access laws, barriers to naloxone remain
MDedge Family Medicine
USPSTF advises primary care to screen for unhealthy alcohol use
MDedge Family Medicine
Despite declines in prenatal use of alcohol and cigarettes, cannabis use is on the rise
MDedge Family Medicine
Harnessing the power of urine tests in pain care
MDedge Family Medicine
Recognize gender expression in youth
MDedge Family Medicine
Overshadowed by opioids, meth is back and hospitalizations surge
MDedge Family Medicine